Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM study [9]

Clinical Chemistry

Volumn 52, Issue 12, 2006, Pages 2313-2314

  Gajdos, Vincent ^a   Petit, François M ^a   Perret, Claire ^b   Mollet Boudjemline, Alix ^a   Colin, Patrice ^a   Capel, Liliane ^a   Nicaud, Viviane ^b   Evans, Alun ^c   Arveiler, Dominique ^d   Parisot, Frédéric ^a   Francoual, Jeanne ^a   Genin, Emmanuelle ^e   Cambien, François ^b   Labrune, Philippe ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b INSERM   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d MONICA Register   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE; TRANSFERASE; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1;

ADULT; ALLELE; CASE CONTROL STUDY; CATALYST; CHI SQUARE TEST; CONFIDENCE INTERVAL; DATA ANALYSIS; DNA DETERMINATION; DNA EXTRACTION; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERBILIRUBINEMIA; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTECTION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TATA BOX; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NOTE;

CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED;

EID: 33845532124     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.078667     Document Type: Letter

References (7)

1. Bosma PJ, van der Meer IM, Bakker CT, Hofman A, Paul-Abrahamse M, Witteman JC. UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003;49:1180-1.
2. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002; 160:449-56.
3. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001;87: 1196-200.
4. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992;12: 701-7.
5. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP- glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
6. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002;22:1680-5.
7. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006; 43:1145-51.